Current view on a role of CD38 for pathogenesis of bronchial asthma
https://doi.org/10.18093/0869-0189-2013-0-5-81-84
Abstract
Current view on a role of CD38 for pathogenesis of bronchial asthma.
About the Authors
I. A. Solovyeva
ГБОУ ВПО "Красноярский государственный медицинский университет им. проф. В.Ф.Войно-Ясенецкого" Минздрава России
Russian Federation
Russian Federation
E. A. Sobko
ГБОУ ВПО "Красноярский государственный медицинский университет им. проф. В.Ф.Войно-Ясенецкого" Минздрава России
Russian Federation
Russian Federation
A. Yu. Kraposhina
ГБОУ ВПО "Красноярский государственный медицинский университет им. проф. В.Ф.Войно-Ясенецкого" Минздрава России
Russian Federation
Russian Federation
I. V. Demko
ГБОУ ВПО "Красноярский государственный медицинский университет им. проф. В.Ф.Войно-Ясенецкого" Минздрава России
Russian Federation
Russian Federation
A. B. Salmina
ГБОУ ВПО "Красноярский государственный медицинский университет им. проф. В.Ф.Войно-Ясенецкого" Минздрава России
Russian Federation
Russian Federation
References
1. Чучалин А.Г. (ред.). Глобальная стратегия лечения и профилактики бронхиальной астмы. М.: Атмосфера; 2007.
2. Федосеев Г.Б. (ред.). Многоликая бронхиальная астма, диагностика, лечение и профилактика. СПб: Нордмедиздат; 2011.
3. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2011. Available on [www.ginasthma.org].
4. Караулов А.В. Новая концепция развития бронхиальной астмы: иммунологические и генетические аспекты. Практикующий врач 1998; 12: 3–4.
5. Deaglio S., Malavasi F. The CD38/CD157 mammalian gene family: an evolutionary paradigm for other leukocyte surface enzymes. Purinergic. Signalling 2006; 2: 431–441.
6. Салмина А.Б., Инжутова А.И., Моргун А.В. и др. НАД+ конвертирующие ферменты в клетках нейрональной и глиальной природы: СD38 как новая молекула-мишень для нейропротекции. Вестник РАМН 2012; 10: 29–37.
7. Higashida H., Salmina A.B., Olovyannikova R.Y. et al. Cyclic ADP-ribose as a universal calcium signal molecule in the nervous system. Neurochem. Int. 2007; 51: 192–199.
8. Salmina A.B., Olovyannikova R.Ya., Mami N. et al. NAD+ metabolism and ADP-ribosyl cyclase as targets for central nervous system therapy. Curr. Med. Chem. 2006; 6 (3): 193–210.
9. Deshpande D.A., White T.A., Guedes A.G.P. et al. Altered airway responsiveness in CD38-deficient mice. Am. J. Respir. Cell Mol. Biol. 2005; 32: 149–156.
10. Malavasi F., Deaglio S., Ferrero E. et al. CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity. Mol. Med. 2006; 12: 334–341.
11. Perraud A.L., Fleig A., Dunn C.A. et al. ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature 2001; 411: 595–599.
12. Prakash Y.S., Kannan M.S., Walseth T.F. et al. Role of cyclic ADPribose in the regulation of [Ca2 +](i) in porcine tracheal smooth muscle. Am. J. Physiol. 1998; 274: 1653–1660.
13. Wills&Karp M., Chiaramonte Wills&Karp M. Interleukin-13 in asthma. Curr. Opin. Pulm. Med. 2003; 9 (1): 21–27.
14. Yamasaki M., Churchill G.C., Galione A. Calcium signalling by nicotinic acid adenine dinucleotidephosphate (NAADP). FEBS J. 2005; 272: 4598–4606.
15. Wang J., Peng Y., Sun Y.W. et al. All-trans retinoic acid induces xaf1 expression through an interferon regulatory factor-1 element in colon cancer. Gastroenterology 2006; 130: 747–758.
16. Zubiaur M., Fernandez O., Ferrero E. et al. CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3-immune receptor tyrosine-based activation motifs. J. Biol. Chem. 2002; 277: 13–22.
17. Laporte J.C., Moore P.E., Baraldo S. et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 2001; 164: 141–148.
18. Feske S. Calcium signalling in lymphocyte activation and disease. Nature Rev. Immunol. 2007; 7: 690–702.
19. Frasca L., Fedele G., Deaglio S. et al. CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells. Blood 2006; 107: 2392–2399.
20. Shore S.A., Moore P.E. Effects of cytokines on contractile and dilator responses of airway smooth muscle. Clin. Exp. Pharmacol. Physiol. 2002; 29 (10): 859–866.
21. Deterre P., Berthelier V., Bauvois B. et al. CD38 in T- and B-cell functions. Chem. Immunol. 2000; 75: 146–168.
22. Hoogsteden H.C., Verhoeven G.T., Lambrecht B.N. et al. Airway inflammation in asthma and chronic obstructive pulmonary disease with special emphasis on the antigenpresenting dendritic cell: influence of treatment with fluticasone propionate. Clin. Exp. Allergy 1999; 29 (2): 116–124.
23. Jahnsen F.L., Moloney E.D., Hogan T. et al. Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 2001; 56: 823–826.
24. Partida&Sanchez S., Goodrich S., Kusser K. еt al. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 2004; 20 (3): 279–291.
25. Partida&Sanchez S., Cockayne D.A., Monard S. et al. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nature Med. 2001; 7: 1209–1216.
26. Thomas P.S. Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol. Cell Biol. 2001; 79 (2): 132–140.
27. Partida&Sanchez S., Rivero&Nava L., Shi G. et al. CD38: an ectoenzyme at the crossroads of innate and adaptive immune responses. Adv. Exp. Med. Biol. 2007; 590: 171–183.
28. Hirota S., Helli P.B., Catalli A. et al. Airway smooth muscle excitation-contraction coupling and airway hyperresponsiveness. Can. J. Physiol. Pharmacol. 2005; 83: 725–732.
29. Alonso D., Radomski M.W. The nitric oxide-endothelin-1 connection. Heart Fail. Rev. 2003; 8 (1): 107–115.
30. Gally F., Hartney J.M., Janssen W.J. et al. CD38 plays a dual role in allergen – induced airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 2009; 40: 433–442.
31. Любавина Н.А., Варварина, Г.Н., Караулов А.В. Влияние стандартной патогенетической терапии на сывороточный уровень на сывороточный уровень молекул SCD38, SCD25 И SCD95 у больных бронхиальной астмой смешанного типа. Иммунология 2011; 32 (5): 267–269.
32. Каптюк Л.И., Крапошина А.Ю., Собко Е.А. и др. Молекулярные механизмы стероидорезистентности при бронхиальной астме: р-гликопротеин и CD38 как новые мишени для фармакологической коррекции. Мол. мед. 2012; 2: 11–16.
33. Собко Е.А., Крапошина А.Ю., Демко И.В. и др. Уровень экспрессии CD38/АДФ-рибозилциклазы и цитокинов периферической крови при бронхиальной астме. Клинико-лабораторный консилиум: спец. вып. 2010; 2–3 (33–34): 61–66.
34. Собко Е.А., Крапошина А.Ю., Демко И.В. и др. Маркер эндотелиальной дисфункции CD38/АДФ-рибозилциклаза при бронхиальной астме. Клин. мед. 2013; 2: 34–38.
35. Scalzo&Inguanti K., Plebanski M. CD38 identifies a hypoproliferative IL-13-secreting CD4+ T-cell subset that does not fit into existing naive and memory phenotype paradigms. Eur. J. Immunol. 2011; 41 (5): 1298–1308.
36. Amrani Y., Panettieri R.A. Jr. Modulation of calcium homeostasis as a mechanism for altering smooth muscle responsiveness in asthma. Curr. Opin. Allergy Clin. Immunol. 2002; 2 (1): 39–45.
37. Tliba O., Panettieri R.A. Jr, Tliba S. et al. Tumor necrosis factor-alpha differentially regulates the expression of proinflammatory genes in human airway smooth muscle cells by activation of interferon-beta-dependent cd38 pathway. Mol. Pharmacol. 2004; 66: 322–329.
38. Jude J.A., Wylam M.E., Walseth T.F. et al. Calcium signaling in airway smooth muscle. Proc. Am. Thorac. Soc. 2008; 5: 15–22.
39. Tenca C., Merlo A., Zarcone D. et al. Death of T cell precursors in the human thymus: a role for CD38. Int. Immunol. 2003; 15: 1105–1116.
40. Kim J., McKinley L., Natarajan S. et al. Anti-tumor necrosis factor-alpha antibody treatment reduces pulmonary inflammation and methacholine hyper-responsiveness in a murine asthma model induced by house dust. Clin. Exp. Allergy 2006; 36 (1): 122–132.
41. White T.A., Xue A., Chini E.N. et al. Role of Transient receptor potential C3 in TNF-α-enhanced calcium influx in human airway myocytes. Am. J. Respir. Cell Mol. Biol. 2006; 35: 243–251.
42. Chung F. Asthma. UK: Eur. Respir. Soc. Ltd; 2003.
43. Tliba O., Damera G., Banerjee A. et al. Cytokines induce an early steroid resistance in airway smooth muscle cells novel role of interferon regulatory factor-1. Am. J. Respir. Cell Mol. Biol. 2008; 38: 463–472.
44. Tirumurugaan K.G., Kang B.N., Panettieri R.A. et al. Regulation of the cd38 promoter in human airway smooth muscle cells by TNF-alpha and dexamethasone. Respir. Res. 2008; 9: 26.
45. Dagia N.M., Harii N., Meli A.E. et al. Phenyl methimazole inhibits tnf-alpha-induced vcam-1 expression in an ifn regulatory factor-1-dependent manner and reduces monocytic cell adhesion to endothelial cells. J. Immunol. 2004; 173: 2041–2049.
46. Yamada K., Elliott W.M., Hayashi S. et al. Latent adenoviral infection modifies the steroid response in allergic lung inflammation. J. Allergy Clin. Immunol. 2000; 106: 844–851.
Review
For citations:
Solovyeva I.A., Sobko E.A., Kraposhina A.Yu., Demko I.V., Salmina A.B. Current view on a role of CD38 for pathogenesis of bronchial asthma. PULMONOLOGIYA. 2013;(5):81-84. (In Russ.) https://doi.org/10.18093/0869-0189-2013-0-5-81-84
Views:
872
Email this article 